414 related articles for article (PubMed ID: 16754256)
1. Molecular genetics and treatment of narcolepsy.
Dauvilliers Y; Tafti M
Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
3. Emerging treatments for narcolepsy and its related disorders.
Nishino S; Okuro M
Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
[TBL] [Abstract][Full Text] [Related]
4. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
Dauvilliers Y
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics in the treatment of narcolepsy.
Tafti M; Dauvilliers Y
Pharmacogenomics; 2003 Jan; 4(1):23-33. PubMed ID: 12517283
[TBL] [Abstract][Full Text] [Related]
6. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
7. Pediatric narcolepsy.
Peterson PC; Husain AM
Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
[TBL] [Abstract][Full Text] [Related]
8. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
Zeitzer JM; Nishino S; Mignot E
Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
10. Treatment of narcolepsy.
Didato G; Nobili L
Expert Rev Neurother; 2009 Jun; 9(6):897-910. PubMed ID: 19496692
[TBL] [Abstract][Full Text] [Related]
11. Advances in narcolepsy.
Cao M
Med Clin North Am; 2010 May; 94(3):541-55. PubMed ID: 20451031
[TBL] [Abstract][Full Text] [Related]
12. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and therapeutic update in narcolepsy].
Santamaria-Cano J
Rev Neurol; 2012 May; 54 Suppl 3():S25-30. PubMed ID: 22605629
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of narcolepsy medications.
Gowda CR; Lundt LP
CNS Spectr; 2014 Dec; 19 Suppl 1():25-33; quiz 25-7, 34. PubMed ID: 25403789
[TBL] [Abstract][Full Text] [Related]
15. EFNS guidelines on management of narcolepsy.
Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy: a review of evidence for autoimmune diathesis.
Black JL
Int Rev Psychiatry; 2005 Dec; 17(6):461-9. PubMed ID: 16401544
[TBL] [Abstract][Full Text] [Related]
17. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
Mignot E
Sleep Med Rev; 2004 Oct; 8(5):333-8. PubMed ID: 15336234
[No Abstract] [Full Text] [Related]
18. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy.
Pedrazzoli M; Pontes JC; Peirano P; Tufik S
Brain Res; 2007 Aug; 1165():1-4. PubMed ID: 17658488
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
Huang YS; Guilleminault C
Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
[TBL] [Abstract][Full Text] [Related]
20. [Narcolepsy with cataplexy].
Dauvilliers Y; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
